#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary ataxia Systemic sclerosis pulmonary Huntington's disease Hyperchylomicronaemia Non-small cell lung cancer recurrent Hereditary haemorrhagic telangiectasia Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Cold type haemolytic anaemia Bladder cancer Marginal zone lymphoma Chondrosarcoma Extra-osseous Ewing's sarcoma recurrent Anal squamous cell carcinoma Carcinoid tumour Stress cardiomyopathy More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX Breast angiosarcoma Metachromatic leukodystrophy – Treatment Progressive multifocal leukoencephalopathy – Life with Disease Primary immunodeficiency syndrome – Trials in Disease Ewing’s sarcoma recurrent Breast angiosarcoma – Trials in Disease Indolent systemic mastocytosis – Basic Information Mantle cell lymphoma refractory – Treatment Chondrosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acetylcysteine Amide Chlorambucil L-ALANINE Batoclimab Rbl016.2 SULBACTAM SODIUM IMB 101 Azathioprine ADX-038 Bepirovirsen Zenocutuzumab Bi 1015550 Letrozole Alternaria Alternata Extract L-Tyrosine Tacrolimus Monohydrate Ro7589655 Bendamustine Hydrochloride Tilsotolimod Sodium Lenograstim More therapies…

    Learn about Your Condition

    Hidradenitis Back pain Osteoporosis postmenopausal Epilepsy Neurodegenerative disorder Indolent systemic mastocytosis Osteotomy Cervix carcinoma stage IV Anorexia nervosa Ependymoma malignant Vaginal haemorrhage Aneurysm ruptured Head and neck cancer Insomnia Mantle cell lymphoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effect of Hydroxychloroquine for Patients with IgA Nephropathy and High Albumin Levels

    Recruiting

    3 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    France

  • Study Comparing Gemcitabine and Paclitaxel Albumin-Bound for Fragile Patients with Non-Resectable Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    Denmark

  • Study of XTMAB-16 and Prednisolone Sodium Phosphate for Patients with Pulmonary Sarcoidosis

    Recruiting

    1 1 1
    Investigated Drugs:
    • Prednisolone Sodium Phosphate
    • Xtmab-16
    Czechia Denmark Italy Poland Spain

  • Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Belgium Bulgaria Czechia Germany Hungary Italy +5

  • Study on Monitoring Ocrelizumab Levels for Personalized Treatment in Patients with Relapsing-Remitting and Primary Progressive Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    Czechia

  • Study on the Use of Platelet Concentrate and Betamethasone for Treating Chronic Low Back Pain in Patients with Lumbar Disc Degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Betamethasone Acetate
    • Platelet Concentrate
    • Betamethasone Sodium Phosphate
    Spain
Previous Page
1 … 362 363 364 365 366 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!